University of Utah
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
September, 2024
September 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« Aug
University of Utah
Aug 9, 2024, 07:48 |
Blog
CancerX is launching a new patient navigation blueprint
CancerX Moonshot shared on LinkedIn: "When a patient receives a cancer diagnosis, their journey ahead…
Aug 5, 2024, 02:38 |
Insight
Umang Swami: Evaluating TRT trends in nonmetastatic castration-resistant prostate cancer
Umang Swami, Oncologist at Huntsman Cancer Institute, University of Utah, shared a post on X about…
Jul 29, 2024, 07:38 |
Blog
Manni Mohyuddin: My personal preference on T cell redirecting therapy for triple class refractory off trial
Manni Mohyuddin shared a post on X: "In absence of head to head data, my…
Jul 14, 2024, 06:27 |
Blog
Georges Gebrael: Baseline bone pain associated with lower survival in mHSPC
Georges Gebrael, Research Fellow at Huntsman Cancer Institute and University of Utah, shared on X/Twitter:…
Jun 24, 2024, 00:16 |
Blog
Huntsman Cancer Institute Collaborative Award for RO1 grant
Umang Swami, Assistant Professor at Huntsman Cancer Institute, University of Utah, shared a post on X:…
May 29, 2024, 02:38 |
Blog
Manni Mohyuddin: On June 8th, I ride at the Huntsman Cancer Institute sportsfest
Manni Mohyuddin shared on X: "On June 8th, I ride at the Huntsman Cancer Institute…
May 9, 2024, 00:05 |
Blog
Fumiko Ladd Chino: Why I think SoMe is essential for the next gen of academic physicians
Fumiko Ladd Chino shared a post by Gita Suneja, Radiation Oncologist at Huntsman Cancer Institute, on…
Apr 29, 2024, 23:03 |
Insight
Manni Mohyuddin: Aaron Goodman and I draw attention to over treatment of multiple myeloma and its precursor states
Manni Mohyuddin, Assistant Professor at the Huntsman Cancer Institute, University of Utah, recently posted on…
Apr 27, 2024, 11:23 |
Insight
APCCC24 Highlights: Lutetium-177 PSMA RLT Toxicity Management by Neeraj Agarwal
Neeraj Agarwal shared on X/Twitter: "How to monitor and manage toxicities with Lutetium-177 PSMA RLT? Luis…
Apr 16, 2024, 13:01 |
Career
Neli Ulrich: I am deeply honored and humbled to receive the Governor's Medal today
Neli Ulrich, Chief Scientific Officer and Executive Director of the Comprehensive Cancer Center at Huntsman…
Apr 14, 2024, 14:15 |
Insight
Neeraj Agarwal: Data from SWOG 1216 trial in mHSPC
Neeraj Agarwal shared on X/Twitter: "Just in: Data from SWOG Cancer Research Network 1216 trial…
Feb 23, 2024, 14:39 |
Insight
Manni Mohyuddin: Why striving for MRD negativity at all costs and having MRD as a primary endpoint may not be ideal
Manni Mohyuddin, Assistant Professor at the Huntsman Cancer Institute at the University of Utah, shared…
Feb 11, 2024, 12:01 |
Insight
Vinay Mathew Thomas: Our viewpoint article on CheckMate 901 is now out in Med by Cell Press
Petros Grivas, Associate Professor at the University of Washington, shared an X post by Vinay…
Jan 6, 2024, 11:43 |
Blog
Manni Mohyuddin: Carfilzomib is NOT better than bortezomib for newly diagnosed myeloma
Manni Mohyuddin, Assistant Professor at the Huntsman Cancer Institute at the University of Utah, shared on…
Dec 17, 2023, 16:45 |
Opinion
Manni Mohyuddin: Sad to see surrogacy word loosely used in a plenary session
Manni Mohyuddin, Assistant Professor at the Huntsman Cancer Institute at the University of Utah, recently…
Dec 16, 2023, 17:08 |
Blog
Manni Mohyuddin: How to treat myeloma after ASH23
Manni Mohyuddin, Assistant Professor at the Huntsman Cancer Institute at the University of Utah, shared…
Dec 13, 2023, 08:51 |
Blog
Manni Mohyuddin: So proud of Sara Zhukovsky for her excellent work on inclusion criteria in myeloma trials
Manni Mohyuddin, Assistant Professor at the Huntsman Cancer Institute at the University of Utah, shared…
Dec 11, 2023, 11:21 |
Opinion
Manni Mohyuddin: Vague enrollment criteria in smoldering myeloma trials opens door to harm/over-interventionalism
Manni Mohyuddin, Assistant Professor at the Huntsman Cancer Institute at the University of Utah, shared…
Nov 6, 2023, 17:36 |
Blog
Manni Mohyuddin: Every day in my clinic, there is selection bias in favor of an increase in PFS for CAR T-cell therapy
Manni Mohyuddin, Assistant Professor at the Huntsman Cancer Institute at the University of Utah, shared…
Oct 1, 2023, 20:03 |
Career
Sumanta K. Pal: I have had the distinct pleasure of working directly with Georges Gebrael.
Sumanta K. Pal, Co-director of City of Hope's Kidney Cancer Program and head of the…
Aug 22, 2023, 18:13 |
Blog
,
Opinion
Cannabis use associated with inferior immunotherapy outcomes OR confounding bias?
Discussions among healthcare professionals ignited on Twitter/X over the following post by Ishwaria Subbiah, the…
All:
21
Posts:
1 - 100
OncoDaily Announces Strategic Partnership with the Asian Fund for Cancer Research Limited (AFCR)
Peyo the Therapy Horse: Comforting Terminally Ill Patients Through Horse Therapy.
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 3
Small Bowel Cancer: Symptoms & Causes, Types, Diagnosis and Treatment
Mikkael A. Sekeres, Candidate for Secretary of ASH
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube